- List
- By Topic
- On Map
- Search Details

endometrium | Recruiting, Not yet recruiting, Available Studies | "Endometrial Neoplasms"
Need help? See RSS Feeds
Choose a feed type:

endometrium | Recruiting, Not yet recruiting, Available Studies | "Endometrial Neoplasms" (20 records)
Need help? See Downloading Content for Analysis
For Advanced Users: Full Study Record XML Download
1 | NCT02767362 | Recruiting | A Pre-Op Window Study Evaluating Anti-Proliferative Effects of Atorvastatin on the Endometrium |
|
|
Interventional | Early Phase 1 |
|
Other |
|
|
24 | Female | 18 Years to 75 Years (Adult, Senior) | NCT02767362 | LCCC 1514 | November 2015 | November 2018 | November 2019 | May 10, 2016 | September 13, 2017 |
|
||
2 | NCT02589366 | Recruiting | Lymphoseek as Lymphoid Tissue Targeting Agent in Patients With Cancer of the Endometrium |
|
|
Interventional | Phase 1 |
|
Other / Industry |
|
|
10 | Female | 18 Years and older (Adult, Senior) | NCT02589366 | HRPP #141163 | November 2015 | November 2017 | November 2017 | October 28, 2015 | June 8, 2017 |
|
||
3 | NCT02288676 | Recruiting | DOvEEgene: Developing and Validating a Novel Molecular Screening Test for the Early Diagnosis of Cancer of the Endometrium, Tubes and Ovaries |
|
Observational |
|
Other |
|
|
280 | Female | 18 Years and older (Adult, Senior) | NCT02288676 | A08-M79-13B | DOvEEgene | January 2014 | December 2019 | December 2020 | November 11, 2014 | March 22, 2017 |
|
|||
4 | NCT03476798 | Not yet recruiting New |
Bevacizumab and Rucaparib in Recurrent Carcinoma of the Cervix or Endometrium |
|
|
Interventional | Phase 2 |
|
Other / Industry |
|
|
55 | Female | 18 Years to 99 Years (Adult, Senior) | NCT03476798 | 8985 | April 2018 | February 2021 | February 2023 | March 26, 2018 | March 26, 2018 |
|
||
5 | NCT02545348 | Recruiting | Use of the Sentinel Node Biopsy for Early Endometrial Cancer. |
|
|
Observational |
|
Other |
|
|
100 | Female | Child, Adult, Senior | NCT02545348 | StLucGsendo1 | SNE | August 2015 | January 2020 | September 2020 | September 9, 2015 | April 26, 2017 |
|
||
6 | NCT03024398 | Not yet recruiting | Evaluation of the Fluorescent Green of Indocyanine in the Detection of Sentinel Lymph Node in Endometrial Cancer |
|
Observational |
|
Other |
|
|
50 | Female | 18 Years and older (Adult, Senior) | NCT03024398 | 6492 | Sentimetre | January 2017 | January 2019 | January 2019 | January 18, 2017 | January 18, 2017 |
|
|||
7 | NCT03438474 | Not yet recruiting | Endometrial Cancer Lymphadenectomy Trial |
|
|
Interventional | Not Applicable |
|
Other |
|
|
640 | Female | 18 Years to 75 Years (Adult, Senior) | NCT03438474 | AGO-OP.6 KKS 228 | ECLAT | March 15, 2018 | February 15, 2028 | February 15, 2029 | February 19, 2018 | February 20, 2018 |
|
|
8 | NCT01977274 | Recruiting | Predictive Clinical and Biological Parameters in Gynecological Cancer - GC-BIO-IPC 2013-010 |
|
|
Interventional | Not Applicable |
|
Other |
|
|
300 | Female | 18 Years and older (Adult, Senior) | NCT01977274 | GC-BIO-IPC 2013-010 | GC-BIO | December 2013 | December 2018 | December 2028 | November 6, 2013 | June 14, 2017 |
|
|
9 | NCT00250770 | Recruiting | Colony-Stimulating Factor-1 (CSF-1) and Other Cytokines in Human Endometrial Carcinogenesis |
|
Observational |
|
Other |
|
750 | Female | Child, Adult, Senior | NCT00250770 | CSF-1 | January 1998 | January 2022 | January 2022 | November 8, 2005 | May 12, 2016 |
|
|||||
10 | NCT03095664 | Recruiting | Effect of a Lifestyle Intervention on Nutritional Status and Prognosis of Endometrial Cancer Survivors |
|
|
Interventional | Not Applicable |
|
Other |
|
|
286 | Female | 20 Years to 69 Years (Adult, Senior) | NCT03095664 | 55155116.9.0000.5274 | November 2016 | November 2023 | November 2023 | March 30, 2017 | April 4, 2017 |
|
||
11 | NCT02730429 | Recruiting | Trial of Letrozole + Palbociclib/Placebo in Metastatic Endometrial Cancer |
|
|
Interventional | Phase 2 |
|
Other |
|
|
78 | Female | 18 Years and older (Adult, Senior) | NCT02730429 | ENGOT-EN3-NSGO/PALEO | February 15, 2017 | December 2020 | December 2022 | April 6, 2016 | April 4, 2017 |
|
||
12 | NCT02774395 | Not yet recruiting | Endometrial Cancer and Fractalkine-receptor Axis of Fractalkine |
|
Observational |
|
Other |
|
|
40 | Female | 18 Years and older (Adult, Senior) | NCT02774395 | 15-AOI-09 | May 2016 | May 2018 | January 2019 | May 17, 2016 | May 17, 2016 |
|
||||
13 | NCT01793545 | Recruiting | Endometrial Cancer Testing With Vaginal and Endometrial Cell Samples |
|
Observational |
|
NIH / Other |
|
|
2000 | Female | 45 Years to 120 Years (Adult, Senior) | NCT01793545 | 999913073 13-C-N073 |
February 14, 2013 | December 1, 2020 | December 1, 2022 | February 15, 2013 | October 27, 2017 |
|
||||
14 | NCT03115593 | Not yet recruiting | Compare the Performance of Targeted Biopsy Versus Aspiration Biopsy With a Pipette for the Diagnosis of Endometrial Cancer |
|
|
Interventional | Not Applicable |
|
Other |
|
|
360 | Female | Child, Adult, Senior | NCT03115593 | CHUB-Hystocor | March 2018 | March 2020 | March 2020 | April 14, 2017 | January 23, 2018 |
|
||
15 | NCT02115477 | Recruiting | Lymphedema After Primary Surgery for Endometrial Cancer |
|
|
Observational |
|
Other |
|
|
260 | Female | 18 Years and older (Adult, Senior) | NCT02115477 | Version 2013-09-22/2014-03-21 The Swedish Cancer Society |
LASEC | April 2014 | June 2017 | June 2018 | April 16, 2014 | February 23, 2016 |
|
||
16 | NCT03300557 | Recruiting | Exemestane in Treating Patients With Complex Atypical Hyperplasia of the Endometrium/Endometrial Intraepithelial Neoplasia or Grade 1 Endometrial Cancer |
|
|
Interventional | Phase 2 |
|
NIH |
|
|
40 | Female | 50 Years and older (Adult, Senior) | NCT03300557 | NCI-2017-01782 N01-CN-2012-00033 2016LS183 / UWI17010/UAB1788 UWI2016-08-01 N01CN00033 P30CA014520 |
November 15, 2017 | December 1, 2018 | December 1, 2018 | October 3, 2017 | March 15, 2018 |
|
||
17 | NCT01686126 | Recruiting | Improving the Treatment for Women With Early Stage Cancer of the Uterus |
|
|
Interventional | Phase 2 |
|
Other |
|
|
165 | Female | 18 Years and older (Adult, Senior) | NCT01686126 | feMMe | feMMe | December 2012 | December 2019 | December 2020 | September 17, 2012 | April 5, 2018 |
|
|
18 | NCT01199250 | Not yet recruiting | Biomarkers in Samples From Patients With Endometrial Cancer |
|
|
Observational |
|
Other / NIH |
|
|
3600 | Female | Child, Adult, Senior | NCT01199250 | GOG-8020 NCI-2011-02868 CDR0000684553 P50CA134254 R01CA071754 R21CA133295 U10CA027469 U10CA037517 |
January 2100 | January 2100 | September 10, 2010 | May 29, 2015 |
|
||||
19 | NCT03245736 | Recruiting | Tisotumab Vedotin Continued Treatment in Patients With Solid Tumors. |
|
|
Interventional | Phase 2 |
|
Industry |
|
|
25 | All | 18 Years and older (Adult, Senior) | NCT03245736 | GCT1015-03 | August 10, 2017 | January 1, 2022 | January 1, 2022 | August 10, 2017 | August 10, 2017 |
|
||
20 | NCT02997553 | Recruiting | Fluorescence for Sentinel Lymph Node Identification in Cancer Surgery |
|
|
Interventional | Phase 3 |
|
Other |
|
|
744 | All | 18 Years and older (Adult, Senior) | NCT02997553 | 2016-A00799-42 | GASVERT | November 29, 2017 | November 2020 | November 2021 | December 20, 2016 | April 17, 2018 |
|
† Study has passed its completion date and status has not been verified in more than two years.